Increased CSF biomarkers of angiogenesis in Parkinson disease
Main Authors: | Janelidze, Shorena, Lindqvist, Daniel, Francardo, Veronica, Hall, Sara, Zetterberg, Henrik, Blennow, Kaj, Adler, Charles H., Beach, Thomas G., Serrano, Geidy E., van Westen, Danielle, Londos, Elisabet, Cenci, M. Angela, Hansson, Oskar |
---|---|
Format: | Online |
Language: | English |
Published: |
Lippincott Williams & Wilkins
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662706/ |
Similar Items
-
Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study
by: Palmqvist, Sebastian, et al.
Published: (2012) -
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
by: Janelidze, Shorena, et al.
Published: (2016) -
Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
by: Janelidze, Shorena, et al.
Published: (2015) -
Plasma β-amyloid in Alzheimer’s disease and vascular disease
by: Janelidze, Shorena, et al.
Published: (2016) -
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
by: Palmqvist, Sebastian, et al.
Published: (2015)